On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.

Yes, I Agree.

The SeriousTraders Newsletter If you are Serious about Trading, become a SeriousTrader!™

Newsletter Archives

SeriousTradersSpotlight Company

INmune Bio Inc. (NASDAQ: INMB)

INmune Bio Inc. (NASDAQ: INMB) is a diversified clinical-stage immunology company developing novel therapies that target distinct parts of a patient’s innate immune system to fight disease. Drug candidates INKmune™ and INB03 may be used to treat cancer while XPro1595 targets neuroinflammation as a cause of Alzheimer’s disease. INmune Bio’s product platforms utilize a precision … Continue reading “INmune Bio Inc. (NASDAQ: INMB)”

View Profile